Table 1.

Number of randomized subjects in the analysis cohort

Analysis Cohort and outcome audiogram	DFMO/Suliudac	Placebo	Total
End-of-treatment audiogram	138	112	250
Discontinued treatment prior to 36 months with off-treatment audiogram performed	20	15	35
36-month audiogram performed	118	97	215
18-Month audiogram	13	27	40
Discontinued treatment prior to 36 months with 18-month audiogram performed only	5	6	11
18-month audiogram performed. Pending 36-month audiogram	8	21	29
Analysis Cohort Total	151	139	290